 |
|
Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
Ga-Young Park, Chung-Hoon Yu, Jun-Seop Kim, Yun-Jeong Kang, Owen Kwon, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park
Korean J Intern Med. 2015;30(3):345-353. Published online 2015 Apr 29 DOI: https://doi.org/10.3904/kjim.2015.30.3.345
|
|
Citations to this article as recorded by
 Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years
Yanhong Chen, Yu Fu, Shixin Wang, Pengsheng Chen, Yunfeng Pei, Jiao Zhang, Rui Zhang, Guoping Niu, Feng Gu, Xiaoli Li
Cardiovascular Diabetology.2022;[Epub] CrossRef Evaluation value of neutrophil gelatinase‐associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta‐analysis
Lulu Guo, Yaya Zhao, Zhenzhu Yong, Weihong Zhao
AGING MEDICINE.2018; 1(2): 185. CrossRef Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort
Laureline Berthelot, Agnès Jamin, Denis Viglietti, Jonathan M Chemouny, Hamza Ayari, Melissa Pierre, Pierre Housset, Virginia Sauvaget, Margarita Hurtado-Nedelec, François Vrtovsnik, Eric Daugas, Zahir Amoura, Vincent Audard, Sonia Azib, Martine Bagot, V
Nephrology Dialysis Transplantation.2017;[Epub] CrossRef Neutrophil gelatinase-associated lipocalin as a predictor of adverse renal outcomes in immunoglobulin A nephropathy
Seong Kwon Ma
The Korean Journal of Internal Medicine.2015; 30(3): 305. CrossRef
|